THE DARK SIDE OF THE COVID-19 TREATMENTS ON MYCOBACTERIUM TUBERCULOSIS INFECTION

Since the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) at the end of 2019, a number of medications have been used to treat the infection and the related Coronavirus disease – 19 (COVID-19). Some of the administered drugs were tested or used in practice only on the bas...

Full description

Bibliographic Details
Main Authors: Flavio De Maio, Delia Mercedes Bianco, Giovanni Delogu
Format: Article
Language:English
Published: Mattioli1885 2022-02-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:http://mjhid.org/index.php/mjhid/article/view/4772